title: Venlafaxine and takotsubo syndrome: Can we learn more from published patient cases?
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, NY, United States; Division of Cardiology, Elmhurst Hospital Center, Elmhurst, NY, United States. Electronic address: madiasj@nychhc.org.
authors.forename: John E
authors.initials: JE
authors.lastname: Madias
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D004562:Electrocardiography / Q000187:drug effects / Q000639:trends; D005260:Female; D006801:Humans; D008875:Middle Aged; D000068760:Serotonin and Noradrenaline Reuptake Inhibitors / Q000009:adverse effects; D054549:Takotsubo Cardiomyopathy / Q000139:chemically induced* / Q000175:diagnosis*; D000069470:Venlafaxine Hydrochloride / Q000009:adverse effects*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D000068760:Serotonin and Noradrenaline Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride
keywords: Pathophysiology of takotsubo syndrome; Serotonin/norepinephrine reuptake inhibitors and takotsubo syndrome; Takotsubo syndrome; Venlafaxine and QRS prolongation; Venlafaxine and QTc prolongation; Venlafaxine and takotsubo syndrome